RPG Life Sciences Launches 'Saksham Niveshak' Campaign for Shareholders
RPG Life Sciences is participating in the 'Saksham Niveshak' campaign to help shareholders claim unpaid dividends and update KYC. This initiative, launched by IEPFA, encourages shareholders to provide updated bank mandates and nominations to avoid dividend transfer to IEPF. Shareholders can submit documents physically or via email.
This is an administrative and compliance-related announcement focused on investor services. It does not involve any significant financial transactions, business operations changes, or strategic shifts that would have a material impact on the company's business or stock.
The announcement is a routine communication about an investor awareness campaign and does not contain any financial performance data or strategic decisions that would positively or negatively impact the company's outlook.
RPG Life Sciences Limited has announced its participation in the Second 100 Days Campaign, "Saksham Niveshak," initiated by the Investor Education and Protection Fund Authority (IEPFA). This campaign, effective from March 27, 2026, aims to assist shareholders in claiming unpaid or unclaimed dividends and updating essential details such as KYC, bank mandates, and nominations.
The company has made a communication regarding this initiative available on its website, www.rpglifesciences.com, to inform its shareholders. The campaign encourages shareholders who have not updated their KYC details, including PAN, nomination, contact information, bank account details, or signatures, to submit the necessary information. This proactive step is crucial to prevent the transfer of unpaid/unclaimed dividends to the IEPF.
For shares held in Demat mode, shareholders need to submit a self-attested copy of their Client Master List with updated particulars and a self-attested PAN Card & Address proof (utility bill not older than 3 months). For shares held in physical mode, Form ISR-1, Form ISR-2 (signature confirmation by bank), and supporting documents are required. Shareholders are also encouraged to provide their choice of nomination using Form SH-13 or Form ISR-3, as per SEBI circular SEBI/HO/MIRSD/POD-1/CIR/2024/81 dated June 10, 2024.
Completed documents can be submitted physically to MUFG Intime India Pvt. Ltd. at C-101, 247 Park, LBS Marg, Vikhroli (West), Mumbai – 400083, or via email to rnt.helpdesk@in.mpms.mufg.com. Rajesh Shirambekar, Head – Legal & Company Secretary, signed the intimation.
What to do with a filing like this
RPG Life Sciences Limited filed this with the NSE as a statutory disclosure, categorised under other investor communications. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by RPG Life Sciences Limited. Read the original for the full detail.